Showing results (241-250 of 265) with videos related to

Sort By:
Pageof 27
The Journal of Antimicrobial Chemotherapy|July 1, 1990
The penetration of roxithromycin into human skinM Campa, I Zolfino, S Senesi, et al.
Nucleosides, Nucleotides & Nucleic Acids|June 15, 2010
Study of apoptosis induction and deoxycytidine kinase/cytidine deaminase modulation in the synergistic interaction of a novel ceramide analog and gemcitabine in pancreatic cancer cellsE Giovannetti, L G Leon, S Bertini, et al.
The Journal of Urology|February 1, 1991
Effect of suramin on human prostate cancer cells in vitroR V La Rocca, R Danesi, M R Cooper, et al.
The Science of the Total Environment|January 10, 2002
Radioecological survey at selected sites hit by depleted uranium ammunitions during the 1999 Kosovo conflictU Sansone, P R Danesi, S Barbizzi, et al.
Prostate Cancer and Prostatic Diseases|January 27, 2021
Androgen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamideM Del Re, V Conteduca, S Crucitta, et al.
Journal of Environmental Radioactivity|December 26, 2002
Depleted uranium particles in selected Kosovo samplesP R Danesi, A Markowicz, E Chinea-Cano, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 3, 2021
What do we need to obtain high quality circulating tumor DNA (ctDNA) for routine diagnostic test in oncology? - Considerations on pre-analytical aspects by the IFCC workgroup cfDNAR Danesi, Y M D Lo, M Oellerich, et al.
ESMO Open|February 4, 2021
Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor BoardsR Danesi, S Fogli, S Indraccolo, et al.
International Journal of Laboratory Hematology|July 21, 2015
Real-Time PCR and Droplet Digital PCR: two techniques for detection of the JAK2(V617F) mutation in Philadelphia-negative chronic myeloproliferative neoplasmsG Fontanelli, C Baratè, E Ciabatti, et al.
British Journal of Cancer|July 18, 2013
VEGF-A polymorphisms predict progression-free survival among advanced castration-resistant prostate cancer patients treated with metronomic cyclophosphamideP Orlandi, A Fontana, A Fioravanti, et al.
Pageof 27